Xizang Haisco Pharmaceutical Group Co Ltd (002653) — Cash Flow-to-Debt Ratio
Xizang Haisco Pharmaceutical Group Co Ltd (002653) has a Cash Flow-to-Debt Ratio of 0.01x as of September 2025, meaning its operating cash flow of CN¥39.68 Million could theoretically repay 0% of its total liabilities (CN¥2.99 Billion) in one year. See Xizang Haisco Pharmaceutical Group Co Lt free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Xizang Haisco Pharmaceutical Group Co Ltd Cash Flow-to-Debt Ratio (2008–2025)
Historical debt coverage capacity for Xizang Haisco Pharmaceutical Group Co Ltd across 18 annual periods. For the full cash flow conversion analysis, see 002653 operating cash flow.
Annual Cash Flow-to-Debt Ratio for Xizang Haisco Pharmaceutical Group Co Ltd (2008–2025)
Year-by-year debt coverage analysis for Xizang Haisco Pharmaceutical Group Co Ltd. Check Xizang Haisco Pharmaceutical Group Co Lt cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.29x | CN¥786.00 Million | CN¥2.72 Billion | ▲ +69.6% |
| 2024 | 0.17x | CN¥442.05 Million | CN¥2.60 Billion | ▼ -6.0% |
| 2023 | 0.18x | CN¥449.58 Million | CN¥2.48 Billion | ▲ +458.3% |
| 2022 | 0.03x | CN¥94.55 Million | CN¥2.91 Billion | ▲ +88.9% |
| 2021 | 0.02x | CN¥35.80 Million | CN¥2.09 Billion | ▼ -82.1% |
| 2020 | 0.10x | CN¥206.21 Million | CN¥2.15 Billion | ▼ -66.6% |
| 2019 | 0.29x | CN¥764.26 Million | CN¥2.66 Billion | ▲ +44.2% |
| 2018 | 0.20x | CN¥472.61 Million | CN¥2.37 Billion | ▲ +8.8% |
| 2017 | 0.18x | CN¥391.81 Million | CN¥2.14 Billion | ▼ -32.9% |
| 2016 | 0.27x | CN¥409.20 Million | CN¥1.50 Billion | ▼ -34.0% |
| 2015 | 0.41x | CN¥443.03 Million | CN¥1.07 Billion | ▼ -36.8% |
| 2014 | 0.65x | CN¥502.57 Million | CN¥767.55 Million | ▼ -38.9% |
| 2013 | 1.07x | CN¥568.41 Million | CN¥530.24 Million | ▼ -45.0% |
| 2012 | 1.95x | CN¥464.75 Million | CN¥238.49 Million | ▼ -14.1% |
| 2011 | 2.27x | CN¥260.79 Million | CN¥114.95 Million | ▲ +9.2% |
| 2010 | 2.08x | CN¥367.38 Million | CN¥176.79 Million | ▲ +20.9% |
| 2009 | 1.72x | CN¥368.21 Million | CN¥214.22 Million | ▲ +152.5% |
| 2008 | 0.68x | CN¥94.45 Million | CN¥138.73 Million | — |